CERo Therapeutics Holdings, Inc. (CERO) NASDAQ

9.63

+0.08(+0.84%)

Updated at June 30 04:00PM

Currency In USD

Valuation

Market Cap3.48M
Enterprise Value1.73M
P/E Ratio-2.38
PEG Ratio0.02
Price/Sales Ratio0
Price/Book Ratio-100.21
Enterprise/Revenue0
Enterprise/EBITDA-0.08

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.74
Return On Equity6.61

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-6.57M
Net Income-7.73M
Diluted EPS-18.15

Balance Sheet

Total Cash5.2M
Total Cash/Share1.52
Total Debt1.37M
Total Debt/Equity-4.15
Current Ratio0.73
Book Value Per Share-0.1

Price History

52-Week Change-98.25
52-Week High896
52-Week Low6.71
Moving Average 50 Days12.1
Moving Average 200 Days104.34

Statistics

Average Volume1.16M
Shares Outstanding516,092
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJune 13, 2025